In a moment...

"Beautiful young people are works of nature, but beautiful old people are works of art.”

The facial aesthetics industry comprising of dermal fillers and injectables is estimated at 5Bn USD globally with a projected growth rate of 11% CAGR till 2023. Facial aesthetics, being a niche therapeutic category, is a high value, low volume industry with limited players.

Xeina Aesthetics, the vertical of Xeina Drugs focussed purely on aesthetics, offers high quality dermal fillers with CE certification and all documentation for global licensing. Xeina has exclusive rights for India and global rights granted for its products portfolio.


FACIAL AESTHETICS PORTFOLIO

ILLUSTRA SOFT

Illustra Soft from Xeina Drugs

Illustra Soft is a gel of cross-linked hyaluronic acid, available as pre filled syringe, is intended for correction of medium depth wrinkles such as forehead lines, frown lines and nasolabial folds (recommended needle is 27G). It is to be injected into the mid dermis.

  PROPERTY  SPECIFICATIONS
AppearanceHomogenous, colorless, transparent viscous gel
HA quantification10.8-13.2 mg/ml
Osmolality280-400 mOsmol/kg
pH6.5-7.4
Dynamic Viscocity24 943-58 200 cP
Residual BDDE≤ 2 ppm
Bacterial endotoxin≤ 0.5 EU/ml
SterilitySterile

ILLUSTRA FINE LINES

Illustra Fine Lines from Xeina Drugs

Illustra Fine Lines is a gel of cross-linked hyaluronic acid indicated for superficial lines, moderate wrinkles and minor skin damages. The product can be used on wrinkles, lines and creases around the mouth. It is to be injected into the superficial and mid dermis (recommended needle is 27G).

  PROPERTY  SPECIFICATIONS
AppearanceHomogenous, colorless, transparent viscous gel
HA quantification16.2-19.8 mg/ml
Osmolality280-400 mOsmol/kg
pH6.5-7.4
Dynamic Viscocity31 642-88 600 cP
Residual BDDE≤ 2 ppm
Bacterial endotoxin≤ 0.5 EU/ml
SterilitySterile

ILLUSTRA ENDURE

Illustra Endure from Xeina Drugs

Illustra Endure is indicated for the correction of deep and severe facial wrinkles and folds. It is to be injected into the deep dermis (recommended needle is 27G).

  PROPERTY  SPECIFICATIONS
AppearanceHomogenous, colorless, transparent viscous gel
HA quantification20.7-25.3 mg/ml
Osmolality280-400 mOsmol/kg
pH6.5-7.4
Dynamic Viscocity70 737-165 000 cP
Residual BDDE≤ 2 ppm
Bacterial endotoxin≤ 0.5 EU/ml
SterilitySterile

ILLUSTRA MAX

Illustra Max from Xeina Drugs

Illustra Max is a gel of cross-linked hyaluronic acid indicated for volume augmentation and facial shape restoration. The product is also indicated for lips contour and volume. The product can be used on severe wrinkles. It is to be injected into the deep dermis or subcutaneously for volume augmentation and mid to deep dermis for injection into lips (recommended needle is 27G).

  PROPERTY  SPECIFICATIONS
AppearanceHomogenous, colorless, transparent viscous gel
HA quantification23.4-28.6 mg/ml
Osmolality280-400 mOsmol/kg
pH6.5-7.4
Dynamic Viscocity72 449-202 000 cP
Residual BDDE≤ 2 ppm
Bacterial endotoxin≤ 0.5 EU/ml
SterilitySterile

MIDASTRA

Midastra from Xeina Drugs
POLY-L-LACTIC ACID 520 MG
Midastra is an injectable cosmetic filler that can be used to restore facial volume lost due to aging or illness. It contains poly-L-lactic acid (PLLA), a biocompatible synthetic substance that stimulates collagen production. It can be used to treat deep lines, creases, and folds to give a more youthful appearance.

PLLA dermal fillers are better than HA fillers Midastraworks subtly and gradually over time for a more youthful-looking appearance. Unlike hyaluronic acid (HA) fillers, Midastra helps stimulate your skin’s own natural collagen production to help restore its inner structure and increase facial volume that has been lost to aging.

Merits of Midastra VS other PLLA Fillers:

  • Quicker dissolution time - under one hour
  • More cost effective
  • Higher volume content of Midastra (520mg) VS other PLLA fillers (150mg) leading to better effects
  • Less volume loss at first injection
  • Low nodule formation - More water --> More dilution --> Lower granuloma

RELATED LINKS - XEINA DRUGS PRODUCT PORTFOLIO:
COVID Portfolio  |  Stem Cell Therapy  |  Finished Dosage Formulations  |  Biosimilars  |  Specialized Products  |  Facial Aesthetics